LFCR
Price
$7.97
Change
+$1.34 (+20.21%)
Updated
Feb 3 closing price
Capitalization
298.79M
Intraday BUY SELL Signals
VTRS
Price
$13.68
Change
+$3.69 (+36.94%)
Updated
Feb 3 closing price
Capitalization
15.76B
26 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LFCR vs VTRS

Header iconLFCR vs VTRS Comparison
Open Charts LFCR vs VTRSBanner chart's image
Lifecore Biomedical
Price$7.97
Change+$1.34 (+20.21%)
Volume$137.76K
Capitalization298.79M
Viatris
Price$13.68
Change+$3.69 (+36.94%)
Volume$8.94M
Capitalization15.76B
LFCR vs VTRS Comparison Chart in %
LFCR
Daily Signal:
Gain/Loss:
VTRS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LFCR vs. VTRS commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Hold and VTRS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (LFCR: $7.97 vs. VTRS: $13.68)
Brand notoriety: LFCR and VTRS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LFCR: 93% vs. VTRS: 105%
Market capitalization -- LFCR: $298.79M vs. VTRS: $15.76B
LFCR [@Pharmaceuticals: Generic] is valued at $298.79M. VTRS’s [@Pharmaceuticals: Generic] market capitalization is $15.76B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.79B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whileVTRS’s FA Score has 3 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • VTRS’s FA Score: 3 green, 2 red.
According to our system of comparison, VTRS is a better buy in the long-term than LFCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 1 TA indicator(s) are bullish while VTRS’s TA Score has 4 bullish TA indicator(s).

  • LFCR’s TA Score: 1 bullish, 8 bearish.
  • VTRS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VTRS is a better buy in the short-term than LFCR.

Price Growth

LFCR (@Pharmaceuticals: Generic) experienced а -8.07% price change this week, while VTRS (@Pharmaceuticals: Generic) price change was +4.27% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.83%. For the same industry, the average monthly price growth was -2.35%, and the average quarterly price growth was +12.98%.

Reported Earning Dates

VTRS is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.83% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($15.8B) has a higher market cap than LFCR($299M). VTRS has higher P/E ratio than LFCR: VTRS (236.20) vs LFCR (51.23). VTRS YTD gains are higher at: 9.880 vs. LFCR (-2.567). LFCR has higher annual earnings (EBITDA): -8.81M vs. VTRS (-598.9M). VTRS has more cash in the bank: 1.16B vs. LFCR (18.9M). LFCR has less debt than VTRS: LFCR (136M) vs VTRS (14.7B). VTRS has higher revenues than LFCR: VTRS (14.1B) vs LFCR (129M).
LFCRVTRSLFCR / VTRS
Capitalization299M15.8B2%
EBITDA-8.81M-598.9M1%
Gain YTD-2.5679.880-26%
P/E Ratio51.23236.2022%
Revenue129M14.1B1%
Total Cash18.9M1.16B2%
Total Debt136M14.7B1%
FUNDAMENTALS RATINGS
LFCR vs VTRS: Fundamental Ratings
LFCR
VTRS
OUTLOOK RATING
1..100
284
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
13
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
446
P/E GROWTH RATING
1..100
51
SEASONALITY SCORE
1..100
6585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (13) in the null industry is significantly better than the same rating for LFCR (95) in the Industrial Specialties industry. This means that VTRS’s stock grew significantly faster than LFCR’s over the last 12 months.

VTRS's Profit vs Risk Rating (100) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that VTRS’s stock grew similarly to LFCR’s over the last 12 months.

VTRS's SMR Rating (96) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that VTRS’s stock grew similarly to LFCR’s over the last 12 months.

VTRS's Price Growth Rating (6) in the null industry is somewhat better than the same rating for LFCR (44) in the Industrial Specialties industry. This means that VTRS’s stock grew somewhat faster than LFCR’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is in the same range as LFCR (5) in the Industrial Specialties industry. This means that VTRS’s stock grew similarly to LFCR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRVTRS
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
62%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 14 days ago
77%
Bullish Trend 3 days ago
71%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 8 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
59%
Aroon
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
LFCR
Daily Signal:
Gain/Loss:
VTRS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ZAP31.030.52
+1.70%
Global X U.S. Electrification ETF
ASHR33.240.16
+0.48%
Xtrackers Harvest CSI 300 China A ETF
BESF36.07N/A
N/A
Bastion Energy ETF
BXSY16.14-0.10
-0.62%
Bexil Investment Trust
MAGX54.90-1.89
-3.33%
Roundhill Daily 2X Lon Mag Sev ETF

LFCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LFCR has been loosely correlated with AMRX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LFCR jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-6.46%
AMRX - LFCR
37%
Loosely correlated
+0.42%
NBIX - LFCR
36%
Loosely correlated
+0.98%
SHPH - LFCR
31%
Poorly correlated
+2.79%
VTRS - LFCR
30%
Poorly correlated
N/A
ALKS - LFCR
30%
Poorly correlated
-1.40%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with AMRX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
N/A
AMRX - VTRS
50%
Loosely correlated
+0.42%
ELAN - VTRS
48%
Loosely correlated
-1.62%
AMPH - VTRS
45%
Loosely correlated
+1.15%
EBS - VTRS
43%
Loosely correlated
-1.45%
ZTS - VTRS
38%
Loosely correlated
-2.02%
More